Abstract
In a recent Consensus Conference, among the 12 maneuvers that led to improved outcome in the perioperative period, inhalational anesthetic agents were the only anesthetic agents identified as contributing to reduced postoperative surgical mortality [1, 2]. Inhalational anesthetic agents have been shown to provide short-term as well as long-term protection [3, 4]. The evidence supporting mortality reduction via inhalational anesthetic agents seems to be growing.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Landoni G, Rodseth RN, Santini F et al (2012) Randomized evidence for reduction of perioperative mortality. J Cardiothorac Vasc Anesth 26:764–772
Landoni G, Pisano A, Lomivorotov V et al (2016) Randomized evidence for reduction of perioperative mortality: an updated consensus process. J Cardiothorac Vasc Anesth. doi:10.1053/j.jvca.2016.07.017. [Epub ahead of print]
Jakobsen CJ, Berg H, Hindsholm KB, Faddy N, Sloth E (2007) The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures. J Cardiothorac Vasc Anesth 21:664–671
Garcia C, Julier K, Bestmann L et al (2005) Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth 94:159–165
Landoni G, Biondi-Zoccai GG, Zangrillo A et al (2007) Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 21:502–511
Fleisher LA, Beckman JA, Brown KA et al (2007) ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines (Writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). J Am Coll Cardiol 50:1707–1732
Landoni G, Greco T, Biondi-Zoccai G et al (2013) Anaesthetic drugs and survival: a Bayesian network meta-analysis of randomized trials in cardiac surgery. Br J Anaesth 111:886–896
Mattheussen M, Rusy BF, Van Aken H et al (1993) Recovery of function and adenosine triphosphate metabolism following myocardial ischemia induced in the presence of volatile anesthetics. Anesth Analg 76:69–75
Boutros A, Wang J, Capuano C (1997) Isoflurane and halothane increase adenosine triphosphate preservation, but do not provide additive recovery of function after ischemia, in preconditioned rat hearts. Anesthesiology 86:109–117
Meybohm P, Bein B, Brosteanu O, Cremer J et al (2015) A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 373:1397–1407
De Hert SG (2006) Volatile anesthetics and cardiac function. Semin Cardiothorac Vasc Anesth 10:33–42
Bignami E, Greco T, Barile L et al (2013) The effect of isoflurane on survival and myocardial infarction: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 27:50–58
Zaugg M, Lucchinetti E, Uecker M et al (2003) Anaesthetics and cardiac preconditioning, part I, signalling and cytoprotective mechanisms. Br J Anaesth 91:551–565
De Hert S, Vlasselaers D, Barbé R et al (2009) A comparison of volatile and non volatile agents for cardio protection during on-pump coronary surgery. Anaesthesia 64:953–960
Hemmerling T, Olivier JF, Le N et al (2008) Myocardial protection by isoflurane vs. sevoflurane in ultra-fast-track anaesthesia for off-pump aortocoronary bypass grafting. Eur J Anaesthesiol 25:230–236
Wang J, Zheng H, Chen CL, Lu W, Zhang YQ (2013) Sevoflurane at 1 MAC provides optimal myocardial protection during off-pump CABG. Scand Cardiovasc J 47:175–184
Suryaprakash S, Chakravarthy M, Muniraju G et al (2013) Myocardial protection during OPCAB surgery: a comparison of inhalational anesthesia with sevoflurane or desflurane and total intravenous anesthesia. Ann Card Anaesth 16:4–8
Landoni G, Fochi O, Bignami E et al (2009) Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth 1:34–43
De Hert SG (2011) Is anaesthetic cardioprotection clinically relevant? Another futile search for a magic bullet? Eur J Anaesthesiol 28:616–617
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Summary Table
Summary Table
Clinical summary | |||||
|---|---|---|---|---|---|
Drug | Indications | Cautions | Side effects | Dosage | Notes |
Inhalational agents | Myocardial protection during general anesthesia for cardiac surgery | Myocardial protection is dose and duration of inhalational anesthetic agent dependent | Common side effects of inhalational agents such as hypotension, myocardial depression, arrhythmias and effects on other solid organs | Unclear at the moment | Myocardial protection, decrease in infarct size and reduction in mortality during cardiac surgery have been well documented |
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Chakravarthy, M., Ruggeri, L. (2017). Role of Inhalational Anesthetic Agents in Reducing Perioperative Mortality. In: Landoni, G., Ruggeri, L., Zangrillo, A. (eds) Reducing Mortality in the Perioperative Period. Springer, Cham. https://doi.org/10.1007/978-3-319-46696-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-46696-5_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46695-8
Online ISBN: 978-3-319-46696-5
eBook Packages: MedicineMedicine (R0)